New York, NY, February 5, 2019 – NMS Capital (“NMS”) announced today the final close of its third private equity fund, NMS Fund III, LP (“Fund III”). Fund III was launched with an initial target of $350 million, and closed at its hard cap of $450 million. NMS’ previous investment fund, NMS Fund II, LP, had commitments of $252 million.
“The team at NMS is immensely grateful for the continued support of so many of our existing investors from prior funds that have chosen to join us again in Fund III,” remarked Martin Chavez, Managing Partner and Co-Founder of NMS. “And we’re also pleased to welcome several new investors that are joining NMS for the first time in Fund III – we look forward to partnering together.”
NMS’ investors are comprised of leading public and corporate pension funds, foundations, family offices and other institutional investors, and are based in the United States and abroad.
Kevin Jordan, Managing Partner and Co-Founder of NMS, said “We’re fortunate to have three platform companies in Fund III already – GrapeTree Medical Staffing, US Foot & Ankle Specialists, and Central Ohio Urology Group – and we are actively working to grow these businesses while seeking additional platform investments. We are thankful to our investor base for creating this opportunity.”
Paul, Weiss, Rifkind, Wharton & Garrison LLP is NMS’ fund counsel and served as legal adviser on Fund III. Stanwich Advisors LLC acted as placement agent for Fund III.
About NMS Capital
NMS Capital is a New York headquartered private investment firm specializing in strategic equity investments and leveraged buyouts of lower middle market companies. The Firm was formed through the spin-out of a group of portfolio companies from the Goldman Sachs Merchant Banking Division. NMS focuses on companies headquartered in the U.S. poised to benefit from sustainable growth trends with particular concentration on companies in Healthcare Services and Specialized Business Services. For additional information on NMS, visit the firm’s website at www.nms-capital.com.